News

Landmark Agreement Signed with RMIT for Australian Medicinal Cannabis Initiatives

Leading Australian research university, Royal Melbourne Institute of Technology and MGC Pharmaceuticals have signed a Binding Memorandum of Understanding to collaborate on a full suite of medicinal cannabis research initiatives, initially centred on genetics and cultivation. Under the…

Industry led consortium accelerates regenerative medicine sector

An industry-led consortium is set to begin projects that will link industry partners with regenerative medicine academic research and boost the growth of this emerging sector. The consortium, called the Regenerative Medicine Industry Interface, will accelerate commercialisation and…

New Hudson Institute Director and CEO announced

We are pleased to announce that Professor Elizabeth Hartland has accepted a position as the new Director and CEO of Hudson Institute of Medical Research. Professor Hartland obtained her BSc (Hons) majoring in Microbiology and Biochemistry and subsequently…

New 4D Scanners Give A Clearer Picture Of Lung Health

A world-first scanner – manufactured right here in Victoria – will provide four-dimensional respiratory analysis to better diagnose and treat lung conditions. Visiting Monash University in Clayton today, Minister for Industry and Employment Wade Noonan was given a…

BioCurate CEO Appointed

An outstanding industry leader with exceptional national and global experience in successfully propelling important biomedical discoveries out of the lab and into the market has been appointed inaugural CEO of BioCurate Pty Ltd.  This AUD $80 million venture…

A Patent Analytics Study on the Australian Advanced Manufacturing Industry

Executive summary Innovation is critical in developing new avenues for economic growth and prosperity for Australia. Innovation can take many different forms and is consequently used and produced by many different businesses. In 2013-14, the manufacturing sector accounted…

10th July – BioBriefing – US Regulatory Landscape: Hills and Valleys at FDA

Monday 10th July – 4:00 pm – 6:00 pm Dr Mary Beth Henderson is the Senior Principal Advisor in Regulatory Affairs and Quality Systems at US based RCRI® (Regulatory & Clinical Research Institute, Inc.). Dr Henderson will be…

2017 Connecting Women – Charity Announced!

The BioMelbourne Network Connecting Women Lunch is now fully booked with over 400 women set to attend on Friday 2nd June. We’re also delighted that we have received a record number of nominations for the BioMelbourne Network Women in Leadership…

More Access To Life-Changing Genomic Testing For Rare Diseases

More Victorian children with rare conditions and diseases will now be able to access world-leading genomic sequencing tests – at no cost – so they can get the diagnosis and treatment they need sooner. The Andrews Labor Government…

Joint statement on the Research & Development Tax Incentive 18 April 2017

Don’t rip the guts out of Australian medical research commercialisation Commercialisation of Australian medical research is under serious threat if the package of measures put by the ‘Ferris, Finkel, Fraser’ Review of the Research & Development (R&D) Tax…

Westpac Businesses of Tomorrow 2017 – Trajan Scientific and Medical Top 20

Right from our very beginning in 1817, Westpac has been guided by the same purpose: TO SUPPORT THE ECONOMIC PROGRESS OF AUSTRALIAN BUSINESSES. As we reach our 200th anniversary, that guiding purpose remains. To help the next generation…

Australia’s ProTA accelerates the development of immunotherapy to treat peanut allergy

Allergy immunotherapy company ProTA Therapeutics Pty Ltd (ProTA) will accelerate the development of a possible treatment for life-threatening peanut allergy with the appointment of its new CEO. ProTA has appointed former Mesoblast Vice President Operations Dr. Suzanne Lipe,…

Home

News & opinion

Member Directory

Events